Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis

This article refers to:

Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis

Tan H, Valdez H, Griffiths C, Mrowietz U, Tallman AM, Wolk R, Gordon KB. (2016) Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis.

http://dx.doi.org/10.1080/09546634.2016.1214671

When the above article was first published online, one of the authors’ names was erroneously written as “Christopher Griffins” instead of “Chris E.M. Griffins.”

This has now been corrected in the online version.

The authors apologise for this error.